These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
506 related items for PubMed ID: 19422483
1. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease. Lemoine M, Ratziu V, Kim M, Maachi M, Wendum D, Paye F, Bastard JP, Poupon R, Housset C, Capeau J, Serfaty L. Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483 [Abstract] [Full Text] [Related]
2. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD. Savvidou S, Hytiroglou P, Orfanou-Koumerkeridou H, Panderis A, Frantzoulis P, Goulis J. J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862 [Abstract] [Full Text] [Related]
3. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH). Krawczyk K, Szczesniak P, Kumor A, Jasinska A, Omulecka A, Pietruczuk M, Orszulak-Michalak D, Sporny S, Malecka-Panas E. J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485 [Abstract] [Full Text] [Related]
4. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Hepatology; 2004 Jul; 40(1):46-54. PubMed ID: 15239085 [Abstract] [Full Text] [Related]
5. Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese. Wong VW, Wong GL, Yu J, Choi PC, Chan AW, Chan HY, Chu ES, Cheng AS, Chim AM, Chan FK, Sung JJ, Chan HL. Am J Gastroenterol; 2010 Jan; 105(1):132-8. PubMed ID: 19809411 [Abstract] [Full Text] [Related]
6. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Chitturi S, Farrell G, Frost L, Kriketos A, Lin R, Fung C, Liddle C, Samarasinghe D, George J. Hepatology; 2002 Aug; 36(2):403-9. PubMed ID: 12143049 [Abstract] [Full Text] [Related]
7. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease. Targher G, Bertolini L, Rodella S, Zoppini G, Scala L, Zenari L, Falezza G. Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671 [Abstract] [Full Text] [Related]
8. Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis. Tiftikci A, Atug O, Yilmaz Y, Eren F, Ozdemir FT, Yapali S, Ozdogan O, Celikel CA, Imeryuz N, Tozun N. Arch Med Res; 2009 May; 40(4):294-8. PubMed ID: 19608019 [Abstract] [Full Text] [Related]
9. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease]. Kim KO, Park SH, Park CH, Han TH, Yoo KS, Kim JH, Lee MS, Kim DJ, Park CK, Cho HD. Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885 [Abstract] [Full Text] [Related]
10. The relationship between serum adiponectin and steatosis in patients with chronic hepatitis C genotype-4. Ashour E, Samy N, Sayed M, Imam A. Clin Lab; 2010 Mar; 56(3-4):103-10. PubMed ID: 20476641 [Abstract] [Full Text] [Related]
11. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis. Ito S, Yukawa T, Uetake S, Yamauchi M. Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172 [Abstract] [Full Text] [Related]
12. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Wong VW, Wong GL, Choi PC, Chan AW, Li MK, Chan HY, Chim AM, Yu J, Sung JJ, Chan HL. Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244 [Abstract] [Full Text] [Related]
13. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. Tsochatzis E, Papatheodoridis GV, Hadziyannis E, Georgiou A, Kafiri G, Tiniakos DG, Manesis EK, Archimandritis AJ. Scand J Gastroenterol; 2008 Jul; 43(9):1128-36. PubMed ID: 18609175 [Abstract] [Full Text] [Related]
14. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C. Giannini E, Botta F, Cataldi A, Tenconi GL, Ceppa P, Barreca T, Testa R. Hepatogastroenterology; 1999 Jul; 46(28):2422-5. PubMed ID: 10522010 [Abstract] [Full Text] [Related]
15. Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia. Inoue M, Yano M, Yamakado M, Maehata E, Suzuki S. Metabolism; 2006 Sep; 55(9):1248-54. PubMed ID: 16919546 [Abstract] [Full Text] [Related]
16. Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis. Shimada M, Kawahara H, Ozaki K, Fukura M, Yano H, Tsuchishima M, Tsutsumi M, Takase S. Am J Gastroenterol; 2007 Sep; 102(9):1931-8. PubMed ID: 17511754 [Abstract] [Full Text] [Related]
17. [Fatty liver disease, insulin resistance and adiponectin in an obese pediatric population]. López-Capapé M, López-Bermejo A, Alonso Blanco M, Lara Orejas E, Corbatón Blasco J, Barrio Castellanos R. An Pediatr (Barc); 2009 Dec; 71(6):495-501. PubMed ID: 19850541 [Abstract] [Full Text] [Related]
18. [Clinical and histological features of non-alcoholic fatty liver disease]. Shi JP, Xun YH, Hu CB, Zhang L, Liu H, Lou GQ, Fan JG. Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638 [Abstract] [Full Text] [Related]
19. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC. Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634 [Abstract] [Full Text] [Related]
20. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Musso G, Gambino R, Durazzo M, Biroli G, Carello M, Fagà E, Pacini G, De Michieli F, Rabbione L, Premoli A, Cassader M, Pagano G. Hepatology; 2005 Nov; 42(5):1175-83. PubMed ID: 16231364 [Abstract] [Full Text] [Related] Page: [Next] [New Search]